Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 5 Neuroblastoma 4 Ganglioneuroblastoma 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Medulloblastoma 3 Wilms Tumor 2 Teratoma 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Embryonal 2 Carcinoma 2 Burkitt Lymphoma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Seizures 1 Sarcoma, Ewing 1 Rhabdomyosarcoma, Alveolar 1

Interventions

Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Laparoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Peritoneal Neoplasms × Magnetic Resonance Spectroscopy × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡